Featured news in The Life Sciences Report
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX) Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch (9/29/2024) |
|
view 
|
|
